Skip to content
Clinical Trials – home

Round cell liposarcoma Life with Disease

2 / 4 trials open to patients6 countries

In short

Round cell liposarcoma is a rare type of cancer that begins in fat cells, usually growing in the arms and legs, and presents unique challenges for patients and their families as they navigate treatment and long-term care.

Key points

  • Round cell liposarcoma typically affects people ages 20 to 40, making it one of the younger-onset types of liposarcoma compared to other subtypes
  • A tumor with more than 5% round cells has a more aggressive behavior and different prognosis than pure myxoid liposarcoma
  • This cancer has an unusual spread pattern—it can go to bones and unusual soft tissue locations rather than just the lungs like many other cancers
  • The five-year survival rate is over 80% when the tumor is small and hasn't spread, highlighting the importance of early detection
  • Round cell liposarcoma is remarkably sensitive to radiation therapy compared to other sarcomas, making it an important treatment option
  • Nearly all cases have a specific genetic fusion (FUS-CHOP genes) that scientists believe is key to understanding and potentially developing targeted treatments
  • Lifelong follow-up is necessary because the cancer can return months or years after successful initial treatment
  • Treatment at specialized sarcoma centers is recommended because these rare cancers require expertise that general cancer centers may not have

Understanding the Outlook and Disease Progression

When someone receives a diagnosis of round cell liposarcoma, one of the first questions that comes to mind is about what the future holds. Prognosis—the medical term for how a disease is expected to affect you over time—varies greatly from person to person with this condition. Understanding prognosis requires looking at several different factors that influence how the disease might progress and respond to treatment.

The outlook for someone with round cell liposarcoma depends significantly on the specific characteristics of their tumor. Where the tumor is located in the body plays an important role in determining prognosis. Tumors that appear in the arms or legs may be easier to treat surgically than those in other locations. Whether the cancer has spread to other parts of the body at the time of diagnosis is another critical factor. The amount of tumor that surgeons can remove during surgery also affects long-term outcomes.

For patients whose round cell liposarcoma is small and has not spread to other parts of the body, the five-year survival rate is over 80%. This statistic represents the percentage of people who are alive five years after their diagnosis. However, it's essential to understand that survival rates are estimates based on large groups of people and cannot predict what will happen to any individual person. Your personal prognosis depends on your unique situation, including your overall health, how your tumor responds to treatment, and other factors that your medical team can help you understand.

The presence of round cells in the tumor is itself a significant factor in prognosis. Round cells get their name from how they appear when examined under a microscope by a medical specialist called a pathologist. When more than 5% of a myxoid liposarcoma tumor consists of these round cells, it is classified as having a round cell component. This designation is important because tumors with a higher percentage of round cells tend to be more aggressive and may have a poorer outcome compared to pure myxoid liposarcoma.

How the Disease Develops Without Treatment

Understanding how round cell liposarcoma behaves when left untreated helps explain why early diagnosis and treatment are so important. This cancer typically begins as cells in fat tissue that have undergone genetic changes, causing them to multiply abnormally and form a tumor. In the early stages, many people do not notice any symptoms at all, which means the tumor can grow silently for months or even years before being discovered.

As the tumor grows larger without treatment, it begins to cause noticeable changes. The most common first sign is a visible lump under the skin, usually on the arms or legs, particularly the thighs. Initially, these lumps are often painless, which can lead people to dismiss them as harmless bumps or assume they will go away on their own. However, unlike harmless fatty lumps called lipomas, round cell liposarcoma will continue to grow and will not disappear without medical intervention.

One of the concerning features of round cell liposarcoma is its ability to spread beyond where it started. Unlike some types of liposarcoma that grow slowly and rarely spread, round cell liposarcoma is more likely to metastasize—the medical term for cancer spreading to other parts of the body. About one-third of people with myxoid/round cell liposarcoma will experience metastasis. This cancer has unusual patterns of spread compared to other cancers. While many cancers primarily spread to the lungs, round cell liposarcoma can spread to unusual locations including bones, soft tissues in other parts of the body, and fatty areas such as those around the heart (pericardium), in the abdomen (retroperitoneum), under the arms (axilla), and in the trunk.

The spread can happen in two different ways. Synchronous spread means that multiple tumors are discovered at the same time in different locations. Metachronous spread means that new tumors appear in other locations at different times, sometimes months or years after the original tumor was treated. This pattern of spread is why people who have been treated for round cell liposarcoma need lifelong follow-up with their medical team to catch any new tumors as early as possible.

Possible Complications and Unexpected Developments

People living with round cell liposarcoma may experience various complications as the disease progresses. These complications can arise from the tumor itself, from the cancer spreading to other areas, or as side effects of treatment. Understanding these possibilities helps patients and families prepare and recognize warning signs that require medical attention.

When a tumor grows large enough, it can press against nearby structures in the body, causing problems depending on its location. A tumor in the leg might press on nerves, leading to pain, numbness, or weakness in that limb. This can make it difficult to walk normally or perform daily activities. If the tumor presses on blood vessels, it might cause swelling or changes in blood flow. In some cases, tumors can affect the function of muscles, making the affected arm or leg feel weak or difficult to use.

When round cell liposarcoma spreads to other parts of the body, complications become more complex and potentially serious. If the cancer spreads to the lungs, it can cause difficulty breathing, persistent cough, or chest pain. Spread to bones can result in bone pain, increased risk of fractures, or problems with the affected bone's structure. When tumors develop in the abdomen or around internal organs, they can cause abdominal pain, cramping, digestive problems, or a gradually increasing belly size as the tumor grows.

Some patients experience general symptoms related to cancer that are not specific to any one location. These can include persistent tiredness that doesn't improve with rest, unexplained weight loss without trying to lose weight, loss of appetite, or nausea. While these symptoms can occur with many conditions, they warrant medical evaluation, especially in someone already diagnosed with round cell liposarcoma.

Another important complication is the possibility of the cancer returning after treatment, known as recurrence. Even when surgery successfully removes all visible tumor, microscopic cancer cells might remain and grow over time. Local recurrence means the cancer comes back in or near the same place where it started. This is why surgeons try to remove not just the tumor but also a margin of normal-looking tissue around it, to catch any invisible cancer cells. Despite these precautions, round cell liposarcoma has a higher risk of recurrence compared to some other types of liposarcoma.

Impact on Daily Life and Coping with Changes

Living with round cell liposarcoma affects many aspects of daily life, extending far beyond the physical symptoms of the disease. The impact touches physical abilities, emotional well-being, social relationships, work responsibilities, and personal activities that bring joy and meaning to life. Understanding these effects helps patients and families prepare for changes and find ways to maintain quality of life throughout treatment and recovery.

Physically, the tumor and its treatment can create significant challenges. A large tumor in the leg can make walking, climbing stairs, or standing for long periods difficult or painful. If the tumor affects an arm, it might interfere with tasks that require strength or fine motor control, such as writing, cooking, or personal care activities. Surgery to remove the tumor often requires a recovery period during which movement is limited and gradual rehabilitation is necessary to regain strength and function. Some patients experience ongoing weakness or limited range of motion in the affected limb even after recovery.

The treatments themselves—surgery, radiation therapy, and chemotherapy—come with their own physical effects that impact daily life. Surgery creates wounds that need time to heal and may leave visible scars. Radiation therapy can cause skin changes, fatigue, and sometimes long-term effects on the treated area. Chemotherapy often causes tiredness, nausea, changes in appetite, and increased vulnerability to infections. These side effects can make it temporarily difficult to perform normal daily activities, work, or care for family members.

Emotionally, a cancer diagnosis brings profound challenges. Many people experience fear and anxiety about the future, worry about whether treatment will work, or concern about how the disease might affect their loved ones. The uncertainty of living with cancer—not knowing exactly how the disease will progress or whether it might return—can create ongoing emotional stress. Some people feel overwhelmed by the amount of medical information they need to understand and the decisions they need to make about treatment. Others struggle with changes to their body image, especially if surgery or treatment leaves visible changes.

Social relationships often shift when someone is living with cancer. Family dynamics may change as relatives try to provide support while managing their own fears and concerns. Friends may struggle to know what to say or how to help. Some people feel isolated because others don't understand what they're going through, especially with a rare cancer that most people have never heard of. Work relationships can become complicated when frequent medical appointments, treatment side effects, or physical limitations affect job performance. Hobbies and recreational activities that once brought joy might become temporarily impossible or require adaptation.

Many patients find that certain strategies help them cope with these challenges. Staying as physically active as possible, within the limits recommended by medical providers, can help maintain strength, improve mood, and provide a sense of control. This might mean gentle walks, physical therapy exercises, or adapted versions of favorite activities. Maintaining social connections, even when energy is limited, helps combat isolation and provides emotional support. This might involve shorter visits, phone calls, video chats, or accepting help from others.

Some people find it helpful to connect with others who have experience with sarcomas, either through support groups, online communities, or patient advocacy organizations. Sharing experiences with people who truly understand the challenges can provide both practical information and emotional support. Others prefer to focus on maintaining as much normalcy as possible in their daily routines, continuing with work, family activities, and hobbies to the extent they can. There is no single right way to cope—each person finds their own path through this experience.

Supporting Family Members Through Clinical Trials

When a loved one has round cell liposarcoma, family members and close friends often want to help but may not know where to start. One important way families can provide support is by helping their loved one understand and access clinical trials, which may offer access to new treatments that could be beneficial. Understanding what clinical trials are, how they work, and how to find appropriate ones can make this support more effective.

Clinical trials are research studies that test new ways to diagnose, treat, or manage diseases. For rare cancers like round cell liposarcoma, clinical trials are particularly important because they may offer access to treatments that are not yet widely available. These studies help researchers understand which treatments work best, what side effects they might cause, and how they compare to existing treatment options. Participating in a clinical trial can sometimes give patients access to promising new therapies before they become standard treatment.

For families wanting to support a loved one in exploring clinical trials, the first step is gathering information together. This can feel overwhelming because medical information is often complex and technical. Families can help by researching available trials online, reading about them together, and making lists of questions to ask the medical team. Major cancer centers and organizations that focus on rare cancers often maintain databases of open clinical trials that families can search. Having a family member or friend help with this research can make the process less daunting and ensure that important details aren't missed.

When considering a specific clinical trial, families can provide invaluable support during the decision-making process. This might involve attending appointments with the medical team to hear explanations about the trial, taking notes during these discussions, and helping the patient think through the potential benefits and risks. Clinical trials have specific requirements about who can participate, based on factors like the size and location of the tumor, whether the cancer has spread, what previous treatments the patient has received, and overall health status. Families can help organize medical records and history to determine if their loved one meets these requirements.

Practical support is equally important when someone participates in a clinical trial. Trials often require frequent visits to the medical center, which might be far from home. Family members can help with transportation, accommodation arrangements if travel is needed, and managing the schedule of appointments. They can help keep track of medications, side effects, and any changes in symptoms that need to be reported to the research team. Clinical trials have specific requirements about how and when treatments are given and what information needs to be collected, so having family support to stay organized can make participation much easier.

It's important for families to understand that clinical trials are voluntary, and patients can decide to stop participating at any time if they wish. The decision to join or not join a clinical trial is deeply personal and should be made based on the patient's values, preferences, and medical situation. Family members can best support their loved one by respecting their decision, whatever it may be, while providing information and practical help without pressure. Simply being present, listening to concerns, and offering reassurance can be some of the most valuable support a family member can provide.

Throughout the experience of dealing with round cell liposarcoma, families should also remember to take care of themselves. Supporting someone with a serious illness can be emotionally and physically exhausting. Finding support for caregivers, whether through counseling, support groups, or help from other family members and friends, is essential. When caregivers take care of their own well-being, they are better able to provide sustained, effective support to their loved one over the long term.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Trabectedin (Yondelis) – An alkylating drug that binds DNA to treat unresectable or metastatic liposarcoma in patients who received prior anthracycline-containing treatment
  • Eribulin (Halaven) – A microtubule inhibitor approved for unresectable or metastatic liposarcoma in patients who received prior anthracycline-containing treatment
  • Doxorubicin – An anthracycline chemotherapeutic agent used as first-line treatment for liposarcoma
  • Ifosfamide – A chemotherapeutic alkylating agent used as first-line treatment for liposarcoma

Did you know?

  1. Round cell liposarcoma has an unusual pattern of spread—unlike most cancers that primarily go to the lungs, it can spread to unusual locations like the heart lining (pericardium) and fatty tissue in unexpected areas of the body.
  2. Almost all cases of myxoid/round cell liposarcoma have a specific genetic change where two genes (FUS and CHOP) join together abnormally, creating a fusion protein that scientists believe is crucial to how the cancer forms.
  3. This type of liposarcoma is extremely sensitive to radiation therapy compared to other sarcomas, making radiation an important part of treatment even though it's a solid tumor type.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Round cell liposarcoma

Recruiting trials first

See all 4 trials →
Quick filters

4 clinical trials in this condition

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ttf-Ngr
  • Sponsor:Universitaet Muenster

Leiomyosarcoma+5

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Intensity Therapeutics Inc.

Myxoid liposarcoma+2

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Afamitresgene Autoleucel
  • Sponsor:USWM Ct LLC

Myxoid liposarcoma+2

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Letetresgene Autoleucel
  • Sponsor:USWM Ct LLC
See all 4 trials →filters applied: condition = Round cell liposarcoma

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).